Document Detail

Recombination and functional studies of a dual-action peptide for diabetes.
MedLine Citation:
PMID:  23336209     Owner:  NLM     Status:  Publisher    
Abstract Objective: To study a recombined chimeric peptide consisting of lysozyme N-terminal sequence and exendin-4 (shortly LYZ(N)-EX4) as a dual-action peptide for diabetes. Methods: LYZ(N)-EX4 was recombined into plasmid pET-32a(+) and expressed in Escherichia coli. The fusion protein was separated by affinity chromatography and hydrolyzed by enterokinase to prepare LYZ(N)-EX4. The chimeric peptide was digested by thrombin and the digests were analyzed by HPLC. The secondary peptides were identified by mass spectrometry. Biological activities of the thrombin digests were determined in vitro, using NIT-1 cells for insulin promoting action and using human white blood cells (WBC) for anti-AGEs action. Results: The fusion protein was highly expressed in E. coli and LYZ(N)-EX4 was obtained via hydrolysis of the fusion protein. The thrombin digests of LYZ(N)-EX4 were separated by HPLC into two peaks, which were identified as LYZ(N) and EX4 by mass spectrametry. Functional studies found that the digests were able to antagonize the effects of AGEs on expression of RAGE mRNA in WBC, promote cell activity, stimulate PDX-1 mRNA expression and increase insulin secretion by NIT-1 cells, suggesting the actions of LYZ(N) and EX4 on the cells. Conclusions: LYZ(N)-EX4 was sensitive to thrombin digestion, and the secondary peptides LYZ(N) and EX4 could function as anti-AGEs and insulin-promoting peptides, respectively.
Jie Zheng; Yuanchang Zhu; Qiuping Yan; Ming Zhong; Suqing Zhao; Yu Liu
Related Documents :
23553969 - Structural and functional characterization of peptides derived from the carboxy-termina...
7914349 - The middle portion in the second cytoplasmic loop of the thyrotropin receptor plays a c...
20847219 - Combined prediction of tat and sec signal peptides with hidden markov models.
7619489 - Variable region sequence modulates periplasmic export of a single-chain fv antibody fra...
7904239 - Intracellular degradation of prohormone-chloramphenicol-acetyl-transferase chimeras in ...
2085669 - Can the topological distribution of membrane spanning amino acid residues be responsibl...
9353739 - Construction of biologically active protein molecular architecture using self-assemblin...
9292009 - Primary induction of human cytotoxic lymphocytes against a synthetic peptide of the hum...
17921259 - Modified form of the fibrinogen bbeta chain (des-gln bbeta), a potential long-lived mar...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-1-22
Journal Detail:
Title:  Journal of drug targeting     Volume:  -     ISSN:  1029-2330     ISO Abbreviation:  J Drug Target     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2013-1-22     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9312476     Medline TA:  J Drug Target     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Faculty of Chemical Engineering and Light Industry, Guangdong University of Technology , Guangzhou , China .
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Sensitivity of the BASC-2 Adaptive Skills Composite in Detecting Adaptive Impairment in a Clinically...
Next Document:  Renin inhibition in the treatment of diabetic kidney disease.